DOI: 10.5281/zenodo.8360337
SOFTWARE: gromacs
TRJ:
- - PE_CL_530Run.xtc
TPR:
- - PE_CL_Run.gro
PREEQTIME: 0
TIMELEFTOUT: 30
TEMPERATURE: 310
COMPOSITION:
  TOCL:
    NAME: TOCL2
    MAPPING: mappingTOCLcharmm.yaml
    COUNT:
    - 30
    - 30
  POPE:
    NAME: POPE
    MAPPING: mappingPOPEcharmm.yaml
    COUNT:
    - 30
    - 30
  SOL:
    NAME: TIP3
    MAPPING: mappingTIP3PCHARMMgui.yaml
    COUNT: 12000
  SOD:
    NAME: SOD
    MAPPING: mappingSOD.yaml
    COUNT: 120
DIR_WRK: /media/osollila/Data2/tmp/DATABANK/
PUBLICATION: Castillo et al, 2022, Mol. Pharmaceutics. 19:1839-1852 (https://doi.org/10.1021/acs.molpharmaceut.1c00926)
AUTHORS_CONTACT: Milka Doktorova
SYSTEM: POPC/TOCL mixture
SOFTWARE_VERSION: null
FF: Charmm36
FF_SOURCE: null
FF_DATE: null
TOP: null
TRAJECTORY_SIZE: 5766486676
TRJLENGTH: 530020.0
NUMBER_OF_ATOMS: 58500
DATEOFRUNNING: 25/09/2023
TYPEOFSYSTEM: lipid bilayer
ID: 772
EXPERIMENT:
  ORDERPARAMETER:
    TOCL: {}
    POPE: {}
  FORMFACTOR: {}
